Consequently, our findings provide evidence that OSMI-1 potentially sensitizes TRAIL-induced cell death in HCT116 cancer cells by blocking the NF-κB signaling pathway and inducing apoptosis through DR5 and JNK activation. Here, MAPK8 is linked to cancer.